SCHEMBL28560116

SCHEMBL28560116

Cc1ccnc2c1c(C)c(C)n2C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.43
▸ NOS3 P29474 2/20 0.35
▸ NOS2 P35228 2/20 0.35
▸ SIRT3 Q9NTG7 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ NTRK1 P04629 5/20 0.33
▸ PIM1 P11309 5/20 0.33
▸ PKMYT1 Q99640 1/20 0.33
▸ ACVR1 Q04771 2/20 0.32
▸ CCNC P24863 2/20 0.32
▸ CDK8 P49336 2/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ TLR8 Q9NR97 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ ABCG2 Q9UNQ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28549707 0.74 PARP1 (0.44) LIMK1PARP1KDM4EL3MBTL1
SCHEMBL17818822 0.72 PTGDR2 (0.39) NTRK1PIM1ACVR1CDK8
SCHEMBL10560583 0.71 ADORA3 (0.35) NOS3NOS2NTRK1L3MBTL1
SCHEMBL4096931 0.70 SLC9A1 (0.36) TDP1PARP1
SCHEMBL20740807 0.68 DAO (0.34) KDM4E
SCHEMBL28442923 0.67 LIMK1 (0.42) LIMK1SIRT3TDP1NTRK1PIM1
SCHEMBL7851904 0.66 NTRK1 (0.35) NTRK1PIM1ACVR1CCNCCDK8
SCHEMBL28360828 0.65 LMNA (0.32) —
SCHEMBL29065343 0.65 KDM4E (0.40) LIMK1NOS3NOS2PARP1KDM4E
SCHEMBL16516801 0.65 LIMK1 (0.75) LIMK1CDK8KDM4EABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 — — CN disclosed
CN-112088157-A Aryl-bipyridine amine derivatives as phosphoinositide kinase inhibitors 拉文纳制药公司 2020-12-15 — — CN disclosed
Send feedback